Cargando…
Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium
BACKGROUND: Hypokalemia is common in patients treated with antihypertensive drugs, but the impact of correcting hypokalemia is insufficiently studied. We examined the consequences of hypokalemia and borderline hypokalemia correction in patients with hypertension. METHODS: We identified 8976 patients...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446172/ https://www.ncbi.nlm.nih.gov/pubmed/32838735 http://dx.doi.org/10.1186/s12872-020-01654-3 |
_version_ | 1783574116086841344 |
---|---|
author | Krogager, Maria Lukács Søgaard, Peter Torp-Pedersen, Christian Bøggild, Henrik Lee, Christina Ji-Young Bonde, Anders Thomassen, Jesper Q. Gislason, Gunnar Pareek, Manan Kragholm, Kristian |
author_facet | Krogager, Maria Lukács Søgaard, Peter Torp-Pedersen, Christian Bøggild, Henrik Lee, Christina Ji-Young Bonde, Anders Thomassen, Jesper Q. Gislason, Gunnar Pareek, Manan Kragholm, Kristian |
author_sort | Krogager, Maria Lukács |
collection | PubMed |
description | BACKGROUND: Hypokalemia is common in patients treated with antihypertensive drugs, but the impact of correcting hypokalemia is insufficiently studied. We examined the consequences of hypokalemia and borderline hypokalemia correction in patients with hypertension. METHODS: We identified 8976 patients with hypertension and plasma potassium concentrations ≤3.7 mmol/L within 100 days from combination antihypertensive therapy initiation. The first measurement between 6 and 100 days after the episode with potassium ≤3.7 mmol/L was retained. We investigated all-cause and cardiovascular mortality within 60-days from the second potassium measurement using Cox regression. Mortality was examined for seven predefined potassium intervals derived from the second measurement: 1.5–2.9 mmol/L (n = 271), 3.0–3.4 mmol/L (n = 1341), 3.5–3.7 (n = 1982) mmol/L, 3.8–4.0 mmol/L (n = 2398, reference), 4.1–4.6 mmol/L (n = 2498), 4.7–5.0 mmol/L (n = 352) and 5.1–7.1 mmol/L (n = 134). RESULTS: Multivariable analysis showed that potassium concentrations 1.5–2.9 mmol/L, 3.0–3.4 mmol/L, 4.7–5.0 mmol/L and 5.1–7.1 mmol/L were associated with increased all-cause mortality (HR 2.39, 95% CI 1.66–3.43; HR 1.36, 95% CI 1.04–1.78; HR 2.36, 95% CI 1.68–3.30 and HR 2.62, 95% CI 1.73–3.98, respectively). Potassium levels <3.0 and > 4.6 mmol/L were associated with increased cardiovascular mortality. The adjusted standardized 60-day mortality risks in the seven strata were: 11.7% (95% CI 8.3–15.0%), 7.1% (95% CI 5.8–8.5%), 6.4% (95% CI 5.3–7.5%), 5.4% (4.5–6.3%), 6.3% (5.4–7.2%), 11.6% (95% CI 8.7–14.6%) and 12.6% (95% CI 8.2–16.9%), respectively. CONCLUSIONS: Persistent hypokalemia was frequent and associated with increased all-cause and cardiovascular mortality. Increase in potassium to levels > 4.6 mmol/L in patients with initial hypokalemia or low normal potassium was associated with increased all-cause and cardiovascular mortality. |
format | Online Article Text |
id | pubmed-7446172 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74461722020-08-26 Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium Krogager, Maria Lukács Søgaard, Peter Torp-Pedersen, Christian Bøggild, Henrik Lee, Christina Ji-Young Bonde, Anders Thomassen, Jesper Q. Gislason, Gunnar Pareek, Manan Kragholm, Kristian BMC Cardiovasc Disord Research Article BACKGROUND: Hypokalemia is common in patients treated with antihypertensive drugs, but the impact of correcting hypokalemia is insufficiently studied. We examined the consequences of hypokalemia and borderline hypokalemia correction in patients with hypertension. METHODS: We identified 8976 patients with hypertension and plasma potassium concentrations ≤3.7 mmol/L within 100 days from combination antihypertensive therapy initiation. The first measurement between 6 and 100 days after the episode with potassium ≤3.7 mmol/L was retained. We investigated all-cause and cardiovascular mortality within 60-days from the second potassium measurement using Cox regression. Mortality was examined for seven predefined potassium intervals derived from the second measurement: 1.5–2.9 mmol/L (n = 271), 3.0–3.4 mmol/L (n = 1341), 3.5–3.7 (n = 1982) mmol/L, 3.8–4.0 mmol/L (n = 2398, reference), 4.1–4.6 mmol/L (n = 2498), 4.7–5.0 mmol/L (n = 352) and 5.1–7.1 mmol/L (n = 134). RESULTS: Multivariable analysis showed that potassium concentrations 1.5–2.9 mmol/L, 3.0–3.4 mmol/L, 4.7–5.0 mmol/L and 5.1–7.1 mmol/L were associated with increased all-cause mortality (HR 2.39, 95% CI 1.66–3.43; HR 1.36, 95% CI 1.04–1.78; HR 2.36, 95% CI 1.68–3.30 and HR 2.62, 95% CI 1.73–3.98, respectively). Potassium levels <3.0 and > 4.6 mmol/L were associated with increased cardiovascular mortality. The adjusted standardized 60-day mortality risks in the seven strata were: 11.7% (95% CI 8.3–15.0%), 7.1% (95% CI 5.8–8.5%), 6.4% (95% CI 5.3–7.5%), 5.4% (4.5–6.3%), 6.3% (5.4–7.2%), 11.6% (95% CI 8.7–14.6%) and 12.6% (95% CI 8.2–16.9%), respectively. CONCLUSIONS: Persistent hypokalemia was frequent and associated with increased all-cause and cardiovascular mortality. Increase in potassium to levels > 4.6 mmol/L in patients with initial hypokalemia or low normal potassium was associated with increased all-cause and cardiovascular mortality. BioMed Central 2020-08-24 /pmc/articles/PMC7446172/ /pubmed/32838735 http://dx.doi.org/10.1186/s12872-020-01654-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Krogager, Maria Lukács Søgaard, Peter Torp-Pedersen, Christian Bøggild, Henrik Lee, Christina Ji-Young Bonde, Anders Thomassen, Jesper Q. Gislason, Gunnar Pareek, Manan Kragholm, Kristian Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium |
title | Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium |
title_full | Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium |
title_fullStr | Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium |
title_full_unstemmed | Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium |
title_short | Impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium |
title_sort | impact of plasma potassium normalization on short-term mortality in patients with hypertension and hypokalemia or low normal potassium |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446172/ https://www.ncbi.nlm.nih.gov/pubmed/32838735 http://dx.doi.org/10.1186/s12872-020-01654-3 |
work_keys_str_mv | AT krogagermarialukacs impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium AT søgaardpeter impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium AT torppedersenchristian impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium AT bøggildhenrik impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium AT leechristinajiyoung impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium AT bondeanders impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium AT thomassenjesperq impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium AT gislasongunnar impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium AT pareekmanan impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium AT kragholmkristian impactofplasmapotassiumnormalizationonshorttermmortalityinpatientswithhypertensionandhypokalemiaorlownormalpotassium |